Soleus Capital is a healthcare investment firm specializing in innovative life sciences, including biotech, medtech, diagnostics, and genomics. The firm invests across the healthcare lifecycle, from developmental-stage companies to commercial enterprises, with a focus on generating superior risk-adjusted returns through catalyst-driven investing in complex and niche opportunities.
The firm's portfolio includes notable companies such as Freenome, Abcuro, and Antios Therapeutics. Soleus Capital typically participates in Series B to Series D funding rounds, with occasional investments in post-IPO equity. Their investment strategy emphasizes identifying unique value propositions within the healthcare sector, supporting companies that drive innovation and advancement in medical technologies and treatments.
Soleus Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
